REG-Biocompatibles Intl.: Statement re Positive Data in Combination Therapy Trial - Reuters PDF Print
ReutersTreatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.